|

Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes

RECRUITINGN/ASponsored by University of California, Davis
Actively Recruiting
PhaseN/A
SponsorUniversity of California, Davis
Started2022-09-15
Est. completion2025-07-01
Eligibility
Age5 Years – 18 Years
Healthy vol.Accepted
Locations1 site

Summary

This study will test the hypothesis that supplemental synchronous video visits and supplemental asynchronous remote monitoring can each significantly improve glycemic control for pediatric patients with uncontrolled type 1 diabetes over a 6 month period, and will compare health outcomes and patient-centered outcomes between these two intervention arms and a control arm receiving usual care.

Eligibility

Age: 5 Years – 18 YearsHealthy volunteers accepted
Inclusion Criteria:

1. age 5-18 years
2. diagnosis of type 1 diabetes with a duration of \>12 months
3. suboptimal glycemic control at time of enrollment, defined as a hemoglobin A1c (HbA1c) level \> 8% (64 mmol/mol) or a 14-day glucose management index (GMI) of \>8% from continuous glucose monitoring (CGM) data or 14-day average blood glucose of \>200 mg/dl in the preceding month
4. intention to receive diabetes care at the UCD Pediatric Diabetes Clinic during the following year
5. access to the internet via a device with video and audio capability
6. ability to connect the patient's home blood glucose meter or CGM device - as well as insulin pump, if applicable - to an internet-capable device via Bluetooth or physical cable.

Exclusion Criteria:

-Patients whose home addresses are not in California (due to current physician licensing restrictions for telehealth services)

Conditions2

DiabetesDiabetes Mellitus, Type 1

Locations1 site

University of California-Davis
Sacramento, California, 95817
Salvador Lopez, BA916-734-4476salo@ucdavis.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.